title: Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection.
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
authors.forename: Julie E
authors.initials: JE
authors.lastname: Bauman
authors.affiliation: Department of Otolaryngology, University of California San Francisco, San Francisco.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Grandis
mesh_terms: D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D000069347:Erlotinib Hydrochloride / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009062:Mouth Neoplasms / Q000517:prevention & control*; D011230:Precancerous Conditions / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D016588:Anticarcinogenic Agents; D047428:Protein Kinase Inhibitors; D000069347:Erlotinib Hydrochloride